糖尿病终末期肾病血液透析临床剖析.docVIP

糖尿病终末期肾病血液透析临床剖析 　　[摘要]目的：探讨糖尿病终末期肾病血液透析治疗临床效果。方法：本次研究对象选自我院2008年5月至2011年5月收治的ESDN型血液透析的患者40例（观察组），就临床资料与同期收治的非糖尿病终末期肾病（NOR-ESDN）型血液透析的患者40例（对照组）作比较分析。结果：观察组血糖水平在透析前明显高于对照组，差异有统计学意义（P0.05）。观察组40例中，1年内死亡人数为9例，占22.5%。 3年死亡人数为24例，占60%。对照组40例中，1年内死亡人数为6例，占15%。3年死亡人数为20例，占50%，观察组3年以上存活率明显低于对照组（P0.05）。观察组1年内死亡9例，对照组为6例，观察组肾功能指标在首次透析存活与死亡患者中存在差异（P0.05）。观察组并发症发生率显著高于对照组，差异具有统计学意义（P0.05）。心血管病变均为两组患者的主要死亡原因。结论：对ESDN采用血液透析的时机进行有效科学的选择，尽量在疾病早期进行，并对感染和心血管疾病加强预防，是降低死亡率，改善患者生活质量的关键。 　　关键词：糖尿病终末期肾病；血液透析；临床分析 　　Clinical analysis of diabetic ESRD hemodialysis 　　[Abstract] Objective： To explore the diabetic ESRD hemodialysis treatment clinical effect. METHODS： This study selected from May 2011， admitted to hospital 2008 the ESDN line hemodialysis patients， 40 cases （observation group）， clinical data were treated in the same period， non-diabetic ESRD （NOR-ESDN） hemodialysis patients， 40 cases （control group） for analysis. Result： the blood glucose level of the observation group was significantly higher in pre-dialysis， the difference was statistically significant （P 0.05）. Observer Group of 40 cases， the deaths of nine cases in one year， accounting for 22.5%. 3-year death toll of 24 cases， accounting for 60%. The control group of 40 cases， the deaths of six cases in one year， accounting for 15%. Three years the number of deaths to 20 cases， accounting for 50%， the survival rate of more than three years of the observation group was significantly lower than the control group （P 0.05）. The observation group within 1 year and 9 died in the control group of six cases， the renal function of the observation group at the first dialysis survival and death in patients with different （P 0.05）. Observation group the incidence of complications was significantly higher， the difference was statistically significant （P 0.05）. Cardiovascular diseases are the leading cause of death of the two groups of patients. Conclusion： ESDN hemodialysis timing line effective choice of science as much as possible